ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics [Internet]. 2018 Jan. 1 [cited 2024 May 7];73:e1err. Available from: https://www.revistas.usp.br/clinics/article/view/144536